Sabo Shasta L, Lahr Jessica M, Offer Madelyn, Weekes Anika LA, Sceniak Michael P
Department of Biology, Central Michigan University, Mount Pleasant, MI, United States.
Program in Biochemistry, Cell and Molecular Biology, Central Michigan University, Mount Pleasant, MI, United States.
Front Synaptic Neurosci. 2023 Jan 10;14:1090865. doi: 10.3389/fnsyn.2022.1090865. eCollection 2022.
-related neurodevelopmental disorder is a rare disease caused by mutations in the gene, which encodes the GluN2B subunit of NMDA receptors. Most individuals with -related neurodevelopmental disorder present with intellectual disability and developmental delay. Motor impairments, autism spectrum disorder, and epilepsy are also common. A large number of pathogenic mutations have been identified in . However, it is not yet known how these variants lead to the clinical symptoms of the disease. Recent research has begun to address this issue. Here, we describe key experimental approaches that have been used to better understand the pathophysiology of this disease. We discuss the impact of several distinct pathogenic variants on NMDA receptor properties. We then critically review pivotal studies examining the synaptic and neurodevelopmental phenotypes observed when disease-associated GluN2B variants are expressed in neurons. These data provide compelling evidence that various GluN2B mutants interfere with neuronal differentiation, dendrite morphogenesis, synaptogenesis, and synaptic plasticity. Finally, we identify important open questions and considerations for future studies aimed at understanding this complex disease. Together, the existing data provide insight into the pathophysiological mechanisms that underlie -related neurodevelopmental disorder and emphasize the importance of comparing the effects of individual, disease-associated variants. Understanding the molecular, cellular and circuit phenotypes produced by a wide range of variants should lead to the identification of core neurodevelopmental phenotypes that characterize the disease and lead to its symptoms. This information could help guide the development and application of effective therapeutic strategies for treating individuals with -related neurodevelopmental disorder.
与[疾病名称]相关的神经发育障碍是一种由[基因名称]基因突变引起的罕见疾病,该基因编码N-甲基-D-天冬氨酸(NMDA)受体的GluN2B亚基。大多数患有与[疾病名称]相关的神经发育障碍的个体表现出智力残疾和发育迟缓。运动障碍、自闭症谱系障碍和癫痫也很常见。在[基因名称]中已经鉴定出大量致病突变。然而,尚不清楚这些变异如何导致该疾病的临床症状。最近的研究已开始解决这个问题。在这里,我们描述了用于更好地理解该疾病病理生理学的关键实验方法。我们讨论了几种不同致病变异对NMDA受体特性的影响。然后,我们批判性地回顾了关键研究,这些研究考察了在神经元中表达与疾病相关的GluN2B变异时观察到的突触和神经发育表型。这些数据提供了令人信服的证据,表明各种GluN2B突变体干扰神经元分化、树突形态发生、突触发生和突触可塑性。最后,我们确定了旨在理解这种复杂疾病的未来研究的重要开放性问题和考虑因素。总之,现有数据深入了解了与[疾病名称]相关的神经发育障碍的病理生理机制,并强调了比较个体疾病相关变异效应的重要性。了解广泛的[基因名称]变异产生的分子、细胞和回路表型应该能够识别出表征该疾病并导致其症状的核心神经发育表型。这些信息有助于指导开发和应用有效的治疗策略来治疗患有与[疾病名称]相关的神经发育障碍的个体。